Bi-cheng Liu – författare

In a world where kidney injury poses an ever-growing threat to human health due to aging populations and changing lifestyles, understanding and combating renal diseases have never been more critical.This book delves into cutting-edge renal disease research, where rapid developments have illuminated new technologies for diagnosis and treatment of the disease. The book systematically and comprehensively addresses clinical issues related to kidney diseases, where readers can explore topics such as hypoxia-inducible factors and renal anemia, pathogenesis of IgA nephropathy, hypertension, diabetic nephropathy, PLA2R antibodies and membranous nephropathy, immune nephropathy treatments using biological agents, renal glucose and energy metabolism, the application of SGLT2 inhibitors, and mechanisms of renal fibrosis.Written by over thirty experts who are actively shaping the field of nephrology in China and the USA, this book offers profound insights to understanding renal diseases, making it an indispensable resource for researchers, clinicians, and readers seeking to grow their knowledge on the scientific issues of kidney disease.

This book systemically presents the latest research on renal fibrosis, covering all the major topics in the field, including the possible mechanisms, biomarkers, and strategies for prevention and treatment of chronic kidney disease (CKD).

This book systemically presents the latest research on renal fibrosis, covering all the major topics in the field, including the possible mechanisms, biomarkers, and strategies for prevention and treatment of chronic kidney disease (CKD).

Renal anemia, one of the common complications in patients with chronic kidney disease, has a high prevalence and seriously affects the quality of life and prognosis of patients.